Aminopyrine

Scientists synthesized a version of the drug labeled with carbon isotopes (

Because aminopyrine is metabolized by the cytochrome P-450 enzymes in the liver, measuring the rate at which a patient exhales labeled CO2CO sub 2 aminopyrine

Due to its potential to cause fatal bone marrow suppression, the U.S. Food and Drug Administration and regulatory bodies in countries like France, Japan, and India suspended its medical use. Despite these bans, it still surfaces in some parts of the developing world. 🔬 Evolution into a Diagnostic Tool Scientists synthesized a version of the drug labeled

Aminopyrine is classified as a tertiary amino compound and a pyrazolone. It continues to be studied in research environments for its chemical reactions and properties: 🔬 Evolution into a Diagnostic Tool Aminopyrine is

While it fell out of favor as a direct therapeutic agent, aminopyrine found a massive secondary life as a non-invasive tool in biomedical diagnostics:

Use of the drug carries a severe risk of agranulocytosis , a condition characterized by a severe lack of white blood cells (neutrophils), leading to extreme vulnerability to infection.